动态准直器旋转联合静态角度端口在大分割全乳放疗中的剂量学研究
结果显示RapidArc Dynamic™降低对侧乳腺、肺和心脏的低剂量暴露,提示其在中国女性解剖特征下可改善危及器官保护。
要点
- RapidArc Dynamic™使对侧乳腺最大剂量降低5.7%(29.6 Gy vs 27.9 Gy),平均剂量降低27.5%(4.0 Gy vs 2.9 Gy)。
- 平均肺剂量降低13%(4.6 Gy vs 4.0 Gy),平均心脏剂量降低21.6%(3.7 Gy vs 2.9 Gy)。
- 研究针对中国女性较小、月牙形乳腺及心脏与靶区距离较近的解剖特征。
核心结论
- RapidArc Dynamic™在中国女性早期左乳腺癌大分割全乳放疗中显著改善危及器官保护。
研究设计与样本
- 所有计划采用6-MV光子、TrueBeam™直线加速器配Millennium 120叶多叶准直器,处方为全乳PTV 40 Gy分15次。
- PTV和OAR剂量参数采用Wilcoxon符号秩检验分析。
主要发现
- RapidArc Dynamic™使对侧乳腺最大剂量降低5.7%(29.6 Gy vs 27.9 Gy),平均剂量降低27.5%(4.0 Gy vs 2.9 Gy)。
- 平均肺剂量降低13%(4.6 Gy vs 4.0 Gy)。
- 平均心脏剂量降低21.6%(3.7 Gy vs 2.9 Gy)。
关键数值与推荐
- 处方剂量为40 Gy分15次至乳腺PTV。
- 对侧乳腺最大剂量29.6 Gy vs 27.9 Gy,平均剂量4.0 Gy vs 2.9 Gy。
- 平均肺剂量4.6 Gy vs 4.0 Gy;平均心脏剂量3.7 Gy vs 2.9 Gy。
临床怎么用
- 对于中国女性早期左乳腺癌大分割全乳放疗,可考虑采用RapidArc Dynamic™以降低对侧乳腺、肺和心脏的低剂量暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whole breast irradiation remains the standard in breast-conserving therapy for early-stage carcinoma. Conventional RapidArc™ plans, while dosimetrically efficient, are limited by fixed collimator position. This often leads to unnecessary irradiation to adjacent organs at risk (OARs)—particularly the contralateral breast, ipsilateral lung, and cardiac structures—resulting in increased low-dose exposure. These challenges are exacerbated in Chinese female patients due to characteristic anatomical features, such as smaller, crescent-shaped breasts, and closer heart-to-target distances. The novel RapidArc Dynamic™ system provides dynamic collimator rotation and static angle ports, enabling more beam shaping during volumetric modulated arc therapy. This study evaluates the implementation of RapidArc Dynamic™ for whole breast irradiation, comparing its dosimetric performance against conventional RapidArc™ in Chinese female patients. METHODS: Ten patients with early-stage left breast cancer were retrospectively replanned using RapidArc™ and RapidArc Dynamic™ on Eclipse™ (v18.1). All plans employed 6-MV photons on a TrueBeam™ linear accelerator equipped with a Millennium 120-leaf MLC, prescribed to deliver 40 Gy in 15 fractions to breast planning target volume for evaluation. Dosimetric parameters for PTV and OARs were analyzed using Wilcoxon signed-rank test. RESULTS: The results demonstrated that RapidArc Dynamic™ reduced contralateral breast exposure by 5.7% in maximum dose (29.6 Gy vs. 27.9 Gy) and 27.5% in mean dose (4.0 Gy vs. 2.9 Gy). Significant doses reductions in lungs were observed with a 13% lower mean lung dose (4.6 Gy vs. 4.0 Gy). Cardiac sparing improved with 21.6% lower mean heart dose (3.7 Gy vs. 2.9 Gy). CONCLUSIONS: RapidArc Dynamic™ demonstrates significant improvement in OARs sparing, despite anatomical challenges in Chinese female patients. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Yuen AHL, Yik MSC, Chung KTH, et al. Integrating static angle ports and dynamic collimator rotation in volumetric modulated arc therapy for hypofractionated whole breast irradiation in Chinese females: a single-centre dosimetric study. Radiat Oncol. 2026. PMID: 41546092. doi:10.1186/s13014-026-02789-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。